Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells

Sorafenib is a multikinase inhibitor and is effective in treating hepatocellular carcinoma (HCC). However, it remains unknown whether sorafenib induces the alteration of protein glycosylation. The present study treated HCC MHCC97L and MHCC97H cells with a 50% inhibitory concentration of sorafenib. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tianhua, Liu, Riqiang, Zhang, Shu, Guo, Kun, Zhang, Qinle, Li, Wei, Liu, Yinkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494657/
https://www.ncbi.nlm.nih.gov/pubmed/28693200
http://dx.doi.org/10.3892/ol.2017.6177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494657/
https://www.ncbi.nlm.nih.gov/pubmed/28693200
http://dx.doi.org/10.3892/ol.2017.6177

Ejemplares similares